JBIO (Jade Biosciences) Marketable Securities: $353.96 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

JBIO Jade Biosciences Inc JBIO
12 GF Score
Price $22.52
! 2 Warning Signs
View Full Analysis

What is Jade Biosciences Marketable Securities?

Jade Biosciences JBIO -4.25% 12 Marketable Securities is $353.96 Mil as of Jun. 2026. GuruFocus rates JBIO with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Jade Biosciences's Marketable Securities for the quarter that ended in Jun. 2026 was $353.96 Mil.

Jade Biosciences's annual Marketable Securities stayed the same from . 20 ($0.00 Mil) to Dec. 2024 ($0.00 Mil) but then increased from Dec. 2024 ($0.00 Mil) to Dec. 2025 ($247.72 Mil).

Jade Biosciences  (NAS:JBIO) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Jade Biosciences Marketable Securities Related Terms

Jade Biosciences Marketable Securities Historical Data

* Premium members only.

The historical data trend for Jade Biosciences's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jade Biosciences Marketable Securities Chart

Jade Biosciences Annual Data
Trend Dec24 Dec25
Marketable Securities
0.00 247.72

Jade Biosciences Quarterly Data
Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial 0.00 148.80 247.72 256.21 353.96
JBIO
12GF Score
Jade Biosciences Inc JBIO
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jade Biosciences Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $353.96 Mil mean?
Jade Biosciences (JBIO) has a Marketable Securities of $353.96 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Jade Biosciences and its competitors.
Is Jade Biosciences' Marketable Securities too high?
Jade Biosciences' current Marketable Securities is $353.96 Mil. Overall, Jade Biosciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Jade Biosciences' Marketable Securities compare to NVAX and AVLN?
Jade Biosciences' Marketable Securities of $353.96 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Biotechnology company?
A good Marketable Securities depends on the Biotechnology industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Jade Biosciences and its competitors. Jade Biosciences's current Marketable Securities is $353.96 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jade Biosciences stock overvalued right now?
Jade Biosciences (JBIO) has a current Marketable Securities of $353.96 Mil. The current Marketable Securities is $353.96 Mil. Jade Biosciences' overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Jade Biosciences (JBIO), the current Marketable Securities is $353.96 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Jade Biosciences Business Description

Address 221 Crescent Street, Building 23, Suite 105, Waltham, MA, USA, 02453
Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its flagship candidate, JADE101, targets the cytokine APRIL and is in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. The company's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, and JADE301, an antibody candidate in preclinical development.
12GF Score

Get the complete analysis for JBIO

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$22.52
Price